These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38360160)

  • 1. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).
    DesJardin JT; Kime N; Kolaitis NA; Kronmal RA; Lammi MR; Mathai SC; Ventetuolo CE; De Marco T;
    J Heart Lung Transplant; 2024 Jun; 43(6):901-910. PubMed ID: 38360160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    DesJardin JT; Kolaitis NA; Kime N; Kronmal RA; Benza RL; Elwing JM; Lammi MR; McConnell JW; Presberg KW; Sager JS; Shlobin OA; De Marco T;
    J Heart Lung Transplant; 2020 Sep; 39(9):945-953. PubMed ID: 32507341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.
    Chang KY; Duval S; Badesch DB; Bull TM; Chakinala MM; De Marco T; Frantz RP; Hemnes A; Mathai SC; Rosenzweig EB; Ryan JJ; Thenappan T;
    J Am Heart Assoc; 2022 May; 11(9):e024969. PubMed ID: 35475351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
    Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
    Garry JD; Kolaitis NA; Kronmal R; Thenappan T; Hemnes A; Grinnan D; Bull T; Chakinala MM; Horn E; Simon MA; De Marco T;
    J Heart Lung Transplant; 2022 Dec; 41(12):1808-1818. PubMed ID: 36150996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Bernardo RJ; Lu D; Ramirez RL; Hedlin H; Kawut SM; Bull T; De Marco T; Ford HJ; Grinnan D; Klinger JR; McConnell JW; Berman-Rosenzweig E; Shlobin OA; Zamanian RT; de Jesus Perez VA
    Ann Am Thorac Soc; 2022 Sep; 19(9):1459-1468. PubMed ID: 35239467
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.
    Fling C; De Marco T; Kime NA; Lammi MR; Oppegard LJ; Ryan JJ; Ventetuolo CE; White RJ; Zamanian RT; Leary PJ
    Ann Am Thorac Soc; 2023 Dec; 20(12):1718-1725. PubMed ID: 37683277
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.
    Strange G; Lau EM; Giannoulatou E; Corrigan C; Kotlyar E; Kermeen F; Williams T; Celermajer DS; Dwyer N; Whitford H; Wrobel JP; Feenstra J; Lavender M; Whyte K; Collins N; Steele P; Proudman S; Thakkar V; Keating D; Keogh A;
    Heart Lung Circ; 2018 Nov; 27(11):1368-1375. PubMed ID: 29029950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry.
    Medrek S; Sahay S; Zhao C; Selej M; Frost A
    J Heart Lung Transplant; 2020 Apr; 39(4):321-330. PubMed ID: 32067864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.
    Khou V; Anderson JJ; Strange G; Corrigan C; Collins N; Celermajer DS; Dwyer N; Feenstra J; Horrigan M; Keating D; Kotlyar E; Lavender M; McWilliams TJ; Steele P; Weintraub R; Whitford H; Whyte K; Williams TJ; Wrobel JP; Keogh A; Lau EM
    Respirology; 2020 Aug; 25(8):863-871. PubMed ID: 31997504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
    Minhas J; Moutchia J; Al-Naamani N; Mazurek JA; Holmes JH; Appleby D; Smith KA; Fritz JS; Pugliese SC; Palevsky HI; Kawut SM
    Ann Am Thorac Soc; 2024 Jun; 21(6):858-865. PubMed ID: 38241602
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Shapiro S; Traiger GL; Turner M; McGoon MD; Wason P; Barst RJ
    Chest; 2012 Feb; 141(2):363-373. PubMed ID: 21757572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Mazimba S; Welch TS; Mwansa H; Breathett KK; Kennedy JLW; Mihalek AD; Harding WC; Mysore MM; Zhuo DX; Bilchick KC
    Heart Lung Circ; 2019 May; 28(5):752-760. PubMed ID: 29748060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
    Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
    JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.